Cargando…

Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4(+) T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele

Despite repeated exposure to HIV-1, certain individuals remain persistently uninfected. Such exposed uninfected (EU) people show evidence of HIV-1–specific T cell immunity and, in rare cases, selective resistance to infection by macrophage-tropic strains of HIV-1. The latter has been associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Furci, Lucinda, Scarlatti, Gabriella, Burastero, Samuele, Tambussi, Giuseppe, Colognesi, Claudia, Quillent, Caroline, Longhi, Renato, Loverro, Patrizia, Borgonovo, Barbara, Gaffi, Davide, Carrow, Emily, Malnati, Mauro, Lusso, Paolo, Siccardi, Antonio G., Lazzarin, Adriano, Beretta, Alberto
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2198997/
https://www.ncbi.nlm.nih.gov/pubmed/9236198
Descripción
Sumario:Despite repeated exposure to HIV-1, certain individuals remain persistently uninfected. Such exposed uninfected (EU) people show evidence of HIV-1–specific T cell immunity and, in rare cases, selective resistance to infection by macrophage-tropic strains of HIV-1. The latter has been associated with a 32–base pair deletion in the C–C chemokine receptor gene CCR-5, the major coreceptor of macrophage-tropic strains of HIV-1. We have undertaken an analysis of the HIV-specific T cell responses in 12 EU individuals who were either homozygous for the wild-type CCR-5 allele or heterozygous for the deletion allele (CCR-5Δ32). We have found evidence of an oligoclonal T cell response mediated by helper T cells specific for a conserved region of the HIV-1 envelope. These cells produce very high levels of C–C chemokines when stimulated by the specific antigen and suppress selectively the replication of macrophage-tropic, but not T cell–tropic, strains of HIV-1. These chemokine-producing helper cells may be part of a protective immune response that could be potentially exploited for vaccine development.